HK Stock Market Move | JINHAI MED TECH (02225) rose over 18% in early trading as the company was included in the Hong Kong Stock Connect list. The revenue structure in the first half of the year has been significantly optimized.

JINHAI MED TECH (02225) surged over 18% in the morning session. As of the time of writing, it is up 15.60%, priced at HKD 4.855, with a trading volume of HKD 57.8683 million. According to news, on September 7, the Shenzhen Stock Exchange announced that, according to the relevant provisions of the "Implementation Rules for Shenzhen-Hong Kong Stock Connect," the list of eligible securities for the Hong Kong Stock Connect has been adjusted and took effect on September 7. Among them, JINHAI MED TECH has been included in the list of eligible stocks for the Hong Kong Stock Connect. This inclusion will help broaden the shareholder base, attract long-term institutional investors, and enhance the liquidity of the shares. It is noteworthy that in the first half of the year, JINHAI MED TECH's revenue structure significantly optimized, successfully shifting its strategic focus from traditional labor services to the high-value-added medical device sector. Revenue from minimally invasive surgical solutions, medical products, and related service fees has risen to account for 74.73%, establishing itself as a new pillar of revenue. Following a strong growth in medical device sales revenue in 2025, the business revenue for the first half of 2026 skyrocketed by 301.5% year-on-year, reaching SGD 25.427 million, providing ample momentum for sustainable growth.